We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Exiqon Licenses microRNA PCR Technology from Rosetta Inpharmatics

News   Nov 20, 2007

 
Exiqon Licenses microRNA PCR Technology from Rosetta Inpharmatics
 
 
 

RELATED ARTICLES

Discovery of Novel Genes May Lead to New Therapies for Muscle Cancer

News

Scientists have uncovered a unique set of genes that play a role in muscle cellular gene expression and differentiation which could lead to new therapeutic targets to prevent the spread of muscle cancer.

READ MORE

Why Not Catching Enough Zzz’s Is Bad for Your Heart

News

In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.

READ MORE

New DNA-nanotechnology Enhances DNA and RNA Analysis

News

A research team has now developed "Signal Amplification by Exchange Reaction" (SABER), a highly programmable and practical method that significantly enhances the sensitivity as well as customization and multiplexing capabilities of Fluorescence in situ hybridization analysis.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE